Scarica l'app Stockscreener
0.5539
3.38%
0.0181
Dopo l'orario di chiusura:
.52
-0.0339
-6.12%
Precedente Chiudi:
$0.5358
Aprire:
$0.533401
Volume 24 ore:
210.84K
Relative Volume:
0.54
Capitalizzazione di mercato:
$23.15M
Reddito:
-
Utile/perdita netta:
$-74.56M
Rapporto P/E:
-0.3024
EPS:
-1.8316
Flusso di cassa netto:
$-60.27M
1 W Prestazione:
+0.09%
1M Prestazione:
-7.65%
6M Prestazione:
+119.98%
1 anno Prestazione:
-49.42%
Intervallo 1D:
$0.5186
$0.5691
Intervallo di 1 settimana:
$0.49
$0.5691
Portata 52W:
$0.2201
$1.2401
Rallybio Corp Stock (RLYB) Company Profile
Nome
Rallybio Corp
Settore
Industria
Telefono
203- 859-3820
Indirizzo
234 CHURCH STREET, NEW HAVEN
Confronta RLYB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RLYB
Rallybio Corp
|
0.5539 | 22.35M | 0 | -74.56M | -60.27M | -1.8316 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-09 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-05-15 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-02-07 | Downgrade | Jefferies | Buy → Hold |
| 2023-04-17 | Iniziato | H.C. Wainwright | Buy |
| 2023-04-10 | Iniziato | Wedbush | Outperform |
| 2022-12-09 | Iniziato | JP Morgan | Overweight |
| 2022-02-22 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-08-23 | Iniziato | Cowen | Outperform |
| 2021-08-23 | Iniziato | Evercore ISI | Outperform |
| 2021-08-23 | Iniziato | Jefferies | Buy |
Mostra tutto
Rallybio Corp Borsa (RLYB) Ultime notizie
Is Rallybio Corporation stock reversal real or fakeWeekly Stock Report & Free High Return Stock Watch Alerts - newser.com
Analyzing Rallybio Corporation with risk reward ratio chartsWeekly Stock Analysis & Daily Growth Stock Investment Tips - newser.com
Will Rallybio Corporation stock beat EPS estimatesJuly 2025 Reactions & Weekly Hot Stock Watchlists - newser.com
Risk adjusted return profile for Rallybio Corporation analyzedGap Up & Free Expert Approved Momentum Trade Ideas - newser.com
Using Ichimoku Cloud for Rallybio Corporation technicalsJuly 2025 Action & Precise Swing Trade Entry Alerts - newser.com
How Rallybio Corporation stock performs in rising dollar environmentWeekly Stock Recap & Safe Investment Capital Preservation Plans - newser.com
Is Rallybio Corporation a candidate for recovery playJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Rallybio (NASDAQ:RLYB) Rating Lowered to “Sell” at Wall Street Zen - Defense World
Rallybio Corporation stock outlook for YEAR2025 Trade Ideas & AI Powered Market Entry Strategies - newser.com
Best data tools to analyze Rallybio Corporation stockGap Up & Weekly High Conviction Ideas - newser.com
What Fibonacci levels say about Rallybio Corporation rebound2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
Is Rallybio Corporation stock attractive for growth ETFsWeekly Trade Analysis & Consistent Income Trade Recommendations - newser.com
Rallybio Corporation (NASDAQ:RLYB) Short Interest Update - Defense World
Will Rallybio Corporation stock benefit from automation2025 Price Momentum & Verified Swing Trading Watchlists - newser.com
Is it too late to sell Rallybio Corporation2025 Winners & Losers & Verified Technical Signals - newser.com
Analysts Set Rallybio Corporation (NASDAQ:RLYB) PT at $5.00 - Defense World
Using data tools to time your Rallybio Corporation exit2025 Year in Review & Weekly Top Gainers Alerts - newser.com
Can Rallybio Corporation stock deliver sustainable ROEQuarterly Market Summary & Verified Momentum Stock Alerts - newser.com
Top chart patterns to watch in Rallybio CorporationMarket Movement Recap & AI Enhanced Trading Signals - newser.com
Rallybio Corporation Stock Analysis and ForecastMarket Capitalization Trends & You’ll Regret Not Buying These Early - earlytimes.in
Recursion to buy Rallybio’s ownership in jointly developed bone disorder drug - MSN
Rallybio completes first cohort dosing in RLYB116 C5 inhibitor study By Investing.com - Investing.com Nigeria
Rallybio Corp Azioni (RLYB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):